Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Feb;63(2):176–179. doi: 10.1038/bjc.1991.43

Familial renal cell carcinoma: clinical and molecular genetic aspects

ER Maher, JRW Yates
PMCID: PMC1971770  PMID: 1997093

Abstract

Renal cell carcinoma (RCC) accounts for 2% of all human cancer, but familial cases are infrequent. Riches (1963) and Griffin et al. (1984) in a population-based case-control study found a family history of renal cell carcinoma in 2.4% of affected patients compared to 1.4% of controls. Nevertheless the importance of inherited tumours in clinical practice and medical research is disproportionate to their frequency. In clinical practice recognition of familial RCC can provide opportunities to prevent morbidity and mortality by appropriate screening. In medical research recent advances in molecular genetics offer the prospect of isolating the genes involved in the pathogenesis of familial RCC and of the more common sporadic cases. In this article we review the clinical and molecular genetics of inherited renal cell carcinoma (adenocarcinoma or hypernephroma).

Full text

PDF
176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergerheim U., Nordenskjöld M., Collins V. P. Deletion mapping in human renal cell carcinoma. Cancer Res. 1989 Mar 15;49(6):1390–1396. [PubMed] [Google Scholar]
  2. Braun W. E., Strimlan C. V., Negron A. G., Straffon R. A., Zachary A. A., Bartee S. L., Grecek D. R. The association of W17 with familial renal cell carcinoma. Tissue Antigens. 1975 Aug;6(2):101–104. doi: 10.1111/j.1399-0039.1975.tb00621.x. [DOI] [PubMed] [Google Scholar]
  3. Cavenee W. K., Dryja T. P., Phillips R. A., Benedict W. F., Godbout R., Gallie B. L., Murphree A. L., Strong L. C., White R. L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. 1983 Oct 27-Nov 2Nature. 305(5937):779–784. doi: 10.1038/305779a0. [DOI] [PubMed] [Google Scholar]
  4. Cohen A. J., Li F. P., Berg S., Marchetto D. J., Tsai S., Jacobs S. C., Brown R. S. Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med. 1979 Sep 13;301(11):592–595. doi: 10.1056/NEJM197909133011107. [DOI] [PubMed] [Google Scholar]
  5. Eker R., Mossige J., Johannessen J. V., Aars H. Hereditary renal adenomas and adenocarcinomas in rats. Diagn Histopathol. 1981 Jan-Mar;4(1):99–110. [PubMed] [Google Scholar]
  6. Erlandsson R., Bergerheim U. S., Boldog F., Marcsek Z., Kunimi K., Lin B. Y., Ingvarsson S., Castresana J. S., Lee W. H., Lee E. A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). Oncogene. 1990 Aug;5(8):1207–1211. [PubMed] [Google Scholar]
  7. Erlandsson R., Boldog F., Sümegi J., Klein G. Do human renal cell carcinomas arise by a double-loss mechanism? Cancer Genet Cytogenet. 1988 Dec;36(2):197–202. doi: 10.1016/0165-4608(88)90145-8. [DOI] [PubMed] [Google Scholar]
  8. Fill W. L., Lamiell J. M., Polk N. O. The radiographic manifestations of von Hippel-Lindau disease. Radiology. 1979 Nov;133(2):289–295. doi: 10.1148/133.2.289. [DOI] [PubMed] [Google Scholar]
  9. Flinter F. A., Abbs S., Bobrow M. Localization of the gene for classic Alport syndrome. Genomics. 1989 Apr;4(3):335–338. doi: 10.1016/0888-7543(89)90339-x. [DOI] [PubMed] [Google Scholar]
  10. Franksson C., Bergstrand A., Ljungdahl I., Magnusson G., Nordenstam H. Renal carcinoma (hypernephroma) occurring in 5 siblings. J Urol. 1972 Jul;108(1):58–61. doi: 10.1016/s0022-5347(17)60641-4. [DOI] [PubMed] [Google Scholar]
  11. Fujita J., Kraus M. H., Onoue H., Srivastava S. K., Ebi Y., Kitamura Y., Rhim J. S. Activated H-ras oncogenes in human kidney tumors. Cancer Res. 1988 Sep 15;48(18):5251–5255. [PubMed] [Google Scholar]
  12. Goldman S. M., Fishman E. K., Abeshouse G., Cohen J. H. Renal cell carcinoma diagnosed in three generations of a single family. South Med J. 1979 Nov;72(11):1457–1459. doi: 10.1097/00007611-197911000-00031. [DOI] [PubMed] [Google Scholar]
  13. Griffin J. P., Hughes G. V., Peeling W. B. A survey of the familial incidence of adenocarcinoma of the kidney. Br J Urol. 1967 Feb;39(1):63–66. doi: 10.1111/j.1464-410x.1967.tb11785.x. [DOI] [PubMed] [Google Scholar]
  14. Grundy P., Koufos A., Morgan K., Li F. P., Meadows A. T., Cavenee W. K. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11. Nature. 1988 Nov 24;336(6197):374–376. doi: 10.1038/336374a0. [DOI] [PubMed] [Google Scholar]
  15. Guirguis A. B. Renal-cell carcinoma. Unusual occurrence in four members of one family. Urology. 1973 Sep;2(3):283–285. doi: 10.1016/0090-4295(73)90465-2. [DOI] [PubMed] [Google Scholar]
  16. Horn L., Horn H. L. An immunological approach to the therapy of cancer? Lancet. 1971 Aug 28;2(7722):466–469. doi: 10.1016/s0140-6736(71)92632-8. [DOI] [PubMed] [Google Scholar]
  17. Horton W. A., Wong V., Eldridge R. Von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Arch Intern Med. 1976 Jul;136(7):769–777. doi: 10.1001/archinte.136.7.769. [DOI] [PubMed] [Google Scholar]
  18. Huson S. M., Harper P. S., Hourihan M. D., Cole G., Weeks R. D., Compston D. A. Cerebellar haemangioblastoma and von Hippel-Lindau disease. Brain. 1986 Dec;109(Pt 6):1297–1310. doi: 10.1093/brain/109.6.1297. [DOI] [PubMed] [Google Scholar]
  19. Ibrahim R. E., Weinberg D. S., Weidner N. Atypical cysts and carcinomas of the kidneys in the phacomatoses. A quantitative DNA study using static and flow cytometry. Cancer. 1989 Jan 1;63(1):148–157. doi: 10.1002/1097-0142(19890101)63:1<148::aid-cncr2820630124>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  20. Jeanpierre C., Antignac C., Beroud C., Lavedan C., Henry I., Saunders G., Williams B., Glaser T., Junien C. Constitutional and somatic deletions of two different regions of maternal chromosome 11 in Wilms tumor. Genomics. 1990 Jul;7(3):434–438. doi: 10.1016/0888-7543(90)90179-x. [DOI] [PubMed] [Google Scholar]
  21. Jennings A. M., Smith C., Cole D. R., Jennings C., Shortland J. R., Williams J. L., Brown C. B. Von Hippel-Lindau disease in a large British family: clinicopathological features and recommendations for screening and follow-up. Q J Med. 1988 Mar;66(251):233–249. [PubMed] [Google Scholar]
  22. Kantor A. F., Blattner W. A., Blot W. J., Fraumeni J. F., Jr, McLaughlin J. K., Schuman L. M., Lindquist L. L., Wang N., Hozier J. C. Hereditary renal carcinoma and chromosomal defects. N Engl J Med. 1982 Nov 25;307(22):1403–1404. doi: 10.1056/nejm198211253072216. [DOI] [PubMed] [Google Scholar]
  23. King C. R., Schimke R. N., Arthur T., Davoren B., Collins D. Proximal 3p deletion in renal cell carcinoma cells from a patient with von Hippel-Lindau disease. Cancer Genet Cytogenet. 1987 Aug;27(2):345–348. doi: 10.1016/0165-4608(87)90017-3. [DOI] [PubMed] [Google Scholar]
  24. Klinger M. E. Renal-cell carcinoma in siblings: a case report. J Am Geriatr Soc. 1968 Sep;16(9):1047–1052. doi: 10.1111/j.1532-5415.1968.tb02735.x. [DOI] [PubMed] [Google Scholar]
  25. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Knudson A. G., Jr, Strong L. C. Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst. 1972 Feb;48(2):313–324. [PubMed] [Google Scholar]
  27. Kovacs G., Brusa P., De Riese W. Tissue-specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal-cell carcinomas. Int J Cancer. 1989 Mar 15;43(3):422–427. doi: 10.1002/ijc.2910430313. [DOI] [PubMed] [Google Scholar]
  28. Kovacs G., Erlandsson R., Boldog F., Ingvarsson S., Müller-Brechlin R., Klein G., Sümegi J. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1571–1575. doi: 10.1073/pnas.85.5.1571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kovacs G., Hoene E. Loss of der(3) in renal carcinoma cells of a patient with constitutional t(3;12). Hum Genet. 1988 Feb;78(2):148–150. doi: 10.1007/BF00278186. [DOI] [PubMed] [Google Scholar]
  30. Kovacs G., Wilkens L., Papp T., de Riese W. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst. 1989 Apr 5;81(7):527–530. doi: 10.1093/jnci/81.7.527. [DOI] [PubMed] [Google Scholar]
  31. Lamiell J. M., Salazar F. G., Hsia Y. E. von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine (Baltimore) 1989 Jan;68(1):1–29. doi: 10.1097/00005792-198901000-00001. [DOI] [PubMed] [Google Scholar]
  32. Li F. P., Marchetto D. J., Brown R. S. Familial renal carcinoma. Cancer Genet Cytogenet. 1982 Nov;7(3):271–275. doi: 10.1016/0165-4608(82)90074-7. [DOI] [PubMed] [Google Scholar]
  33. Lyons A. R., Logan H., Johnston G. W. Hypernephroma in two brothers. Br Med J. 1977 Mar 26;1(6064):816–817. doi: 10.1136/bmj.1.6064.816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. MELMON K. L., ROSEN S. W. LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED. Am J Med. 1964 Apr;36:595–617. doi: 10.1016/0002-9343(64)90107-x. [DOI] [PubMed] [Google Scholar]
  35. Maher E. R., Yates J. R., Ferguson-Smith M. A. Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet. 1990 May;27(5):311–314. doi: 10.1136/jmg.27.5.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mathieson P. W. Renal carcinoma with a strong family history. Br J Urol. 1986 Aug;58(4):458–459. doi: 10.1111/j.1464-410x.1986.tb09108.x. [DOI] [PubMed] [Google Scholar]
  37. McLaughlin J. K., Mandel J. S., Blot W. J., Schuman L. M., Mehl E. S., Fraumeni J. F., Jr A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst. 1984 Feb;72(2):275–284. [PubMed] [Google Scholar]
  38. Pathak S., Strong L. C., Ferrell R. E., Trindade A. Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. Science. 1982 Sep 3;217(4563):939–941. doi: 10.1126/science.7112106. [DOI] [PubMed] [Google Scholar]
  39. Pearson H. H. Familial renal tumours. Aust N Z J Surg. 1969 May;38(4):333–338. [PubMed] [Google Scholar]
  40. Pilepich M. V., Berkman E. M., Goodchild N. T. HLA typing in familial renal carcinoma. Tissue Antigens. 1978 May;11(5):487–488. doi: 10.1111/j.1399-0039.1978.tb01290.x. [DOI] [PubMed] [Google Scholar]
  41. RICHES E. On carcinoma of the kidney. Ann R Coll Surg Engl. 1963 Apr;32:201–208. [PMC free article] [PubMed] [Google Scholar]
  42. RUSCHE C. Silent adenocarcinoma of the kidney with solitary metastases occurring in brothers. J Urol. 1953 Aug;70(2):146–151. doi: 10.1016/S0022-5347(17)67886-8. [DOI] [PubMed] [Google Scholar]
  43. Reddy E. R. Bilateral renal cell carcinoma--unusual occurrence in three members of one family. Br J Radiol. 1981 Jan;54(637):8–11. doi: 10.1259/0007-1285-54-637-8. [DOI] [PubMed] [Google Scholar]
  44. Seizinger B. R., Rouleau G. A., Ozelius L. J., Lane A. H., Farmer G. E., Lamiell J. M., Haines J., Yuen J. W., Collins D., Majoor-Krakauer D. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature. 1988 Mar 17;332(6161):268–269. doi: 10.1038/332268a0. [DOI] [PubMed] [Google Scholar]
  45. Shimizu M., Yokota J., Mori N., Shuin T., Shinoda M., Terada M., Oshimura M. Introduction of normal chromosome 3p modulates the tumorigenicity of a human renal cell carcinoma cell line YCR. Oncogene. 1990 Feb;5(2):185–194. [PubMed] [Google Scholar]
  46. Smith S. J., Bosniak M. A., Megibow A. J., Hulnick D. H., Horii S. C., Raghavendra B. N. Renal cell carcinoma: earlier discovery and increased detection. Radiology. 1989 Mar;170(3 Pt 1):699–703. doi: 10.1148/radiology.170.3.2644658. [DOI] [PubMed] [Google Scholar]
  47. Solomon D., Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol. 1988 Sep;19(9):1072–1079. doi: 10.1016/s0046-8177(88)80089-3. [DOI] [PubMed] [Google Scholar]
  48. Steinberg S. M., Brodovsky H. S., Goepp C. E. Renal carcinoma in mother and daughter. Cancer. 1972 Jan;29(1):222–225. doi: 10.1002/1097-0142(197201)29:1<222::aid-cncr2820290133>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  49. Teyssier J. R., Henry I., Dozier C., Ferre D., Adnet J. J., Pluot M. Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus. J Natl Cancer Inst. 1986 Dec;77(6):1187–1195. [PubMed] [Google Scholar]
  50. Tory K., Brauch H., Linehan M., Barba D., Oldfield E., Filling-Katz M., Seizinger B., Nakamura Y., White R., Marshall F. F. Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl Cancer Inst. 1989 Jul 19;81(14):1097–1101. doi: 10.1093/jnci/81.14.1097. [DOI] [PubMed] [Google Scholar]
  51. Valleteau de Moulliac M., Ganansia R., Hors J., Letexier A., Morin M. Cancer du rein familial et système H.L.A. Quatre cancers du rein gauche dans une fratrie. Nouv Presse Med. 1974 Jun 15;3(24):1539–1542. [PubMed] [Google Scholar]
  52. Wang N., Perkins K. L. Involvement of band 3p14 in t(3;8) hereditary renal carcinoma. Cancer Genet Cytogenet. 1984 Apr;11(4):479–481. doi: 10.1016/0165-4608(84)90028-1. [DOI] [PubMed] [Google Scholar]
  53. Yoshida M. A., Ohyashiki K., Ochi H., Gibas Z., Pontes J. E., Prout G. R., Jr, Huben R., Sandberg A. A. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res. 1986 Apr;46(4 Pt 2):2139–2147. [PubMed] [Google Scholar]
  54. Zbar B., Brauch H., Talmadge C., Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. 1987 Jun 25-Jul 1Nature. 327(6124):721–724. doi: 10.1038/327721a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES